Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease by Leng, H, Zhang, H, Li, L, Zhang, S, Wang, Y, Chavda, SJ, Galas-Filipowicz, D, Lou, H, Ersek, A, Morris, EV, Sezgin, E, Lee, Y-H, Li, Y, Lechuga-Vieco, AV, Tian, M, Mi, J-Q, Yong, K, Zhong, Q, Edwards, CM, Simon, AK, Horwood, NJ

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease by Ersek, A, Xu, K, Antonopoulos, A, Butters, TD, Santo, AE, Vattakuzhi, Y, Williams, LM, Goudevenou, K, Danks, L, Freidin, A, Spanoudakis, E, Parry, S, Papaioannou, M, Hatjiharissi, E, Chaidos, A, Alonzi, DS, Twigg, G, Hu, M, Dwek, RA, Haslam, S, Roberts, I, Dell, A, Rahemtulla, A, Horwood, NJ, Karadimitris, A